Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain
- 1 June 1997
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 3 (6) , 632-638
- https://doi.org/10.1038/nm0697-632
Abstract
We demonstrate here that synthetic 22-mer peptide 46, corresponding to the car boxy-terminal amino acid residues 361–382 of p53, can activate specific DNA binding of wild-type p53 in vitro and can restore the transcriptional transactivating function of at least some mutant p53 proteins in living cells. Introduction of peptide 46 in Saos-2 cells carrying a Tet-regulatable His-273 mutant p53 construct caused growth inhibition and apoptosis in the presence of mutant p53 but not in its absence, confirming that the effect of the peptide is mediated by reactivation of mutant p53. Moreover, peptide 46 caused apoptosis in mutant as well as wild-type p53-carrying human tumor cell lines of different origin, whereas p53 null tumor cells were not affected. These findings raise possibilities for developing drugs that restore the tumor suppressor function of mutant p53 proteins, thus selectively eliminating tumor cells.Keywords
This publication has 18 references indexed in Scilit:
- Small peptides activate the latent sequence-specific DNA binding function of p53Cell, 1995
- The Retro-inverso Form of a Homeobox-Derived Short Peptide Is Rapidly Internalized by Cultured Neurons: A New Basis for an Efficient Intracellular Delivery SystemBiochemical and Biophysical Research Communications, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Allosteric activation of latent p53 tetramersCurrent Biology, 1994
- p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 1994
- Dispersion Polymerizations in Supercritical Carbon DioxideScience, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990